Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

Recruiting now · Not applicable

Conditions studied: Orbital Neoplasms

In brief

To evaluate the potential usefulness of 18F-AlF-FAPI positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in orbital neoplasms, and compared with 18F-FDG PET/CT.

Key facts

Study ID

NCT06791226

Run by

Peking University Third Hospital

People needed

50

Starts

2024-07-16

Expected to finish

2028-12-31

Last updated by the study team

2025-01-24

Who can join

Age: 3 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patients with suspected or newly diagnosed orbital neoplasms (supporting evidence may include MRI, CT and pathology report);
• patients who had scheduled both 18F-FDG and 18F-AlF-FAPI PET/CT scans;
• patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.

You may not qualify if…

• patients with pregnancy;
• breastfeeding;
• the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.

Where it is running

• Dept. of Nuclear Medicine, Peking University Third Hospital — Beijing, Beijing Municipality, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.